Therefore, given the above findings, we undertook an evaluation aimed at molecular docking and the ability for inhibition of BCRP, MDR1, and MRP1 resistance proteins by the novel selenoesters EDAG-1 and EDAG-8 in MCF-7 and MDA-MB-231 breast cancer cells. This evidence concerns the gene ABCG2 and breast carcinoma.